AssetMark Inc
AMED

AssetMark Inc’s Amedisys AMED Stock Holding History

AssetMark Inc’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-22
Closed -$2.17K – 3186
2025
Q2 		$2.17K Buy
+22
New +$2.08K ﹤0.01% 2407
2022
Q1 		– Sell
-3
Closed – – 1539
2021
Q4 		$0 Hold
3
– – ﹤0.01% 1501
2021
Q3 		$0 Buy
+3
New +$624 ﹤0.01% 1386
2021
Q2 		– Sell
-9
Closed -$2K – 1313
2021
Q1 		$2K Buy
9
+3
+50% +$846 ﹤0.01% 1153
2020
Q4 		$2K Hold
6
– – ﹤0.01% 1168
2020
Q3 		$1K Hold
6
– – ﹤0.01% 1192
2020
Q2 		$1K Buy
6
+1
+20% +$187 ﹤0.01% 1151
2020
Q1 		$1K Sell
5
-3
-38% -$534 ﹤0.01% 1234
2019
Q4 		$1K Hold
8
– – ﹤0.01% 1287
2019
Q3 		$1K Sell
8
-2
-20% -$260 ﹤0.01% 1207
2019
Q2 		$1K Buy
10
+4
+67% +$475 ﹤0.01% 1209
2019
Q1 		$1K Buy
+6
New +$753 ﹤0.01% 1213
2018
Q1 		– Sell
-9
Closed – – 1418
2017
Q4 		$0 Buy
+9
New +$474 ﹤0.01% 1857

Other funds holding AMED

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
MCI
MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

AssetMark Inc's AMED Position: Q3 2025 in Review

AssetMark Inc sold out of Amedisys (AMED) in Q3 2025, closing a stake of 22 shares — an estimated $2.17K sold.

AssetMark Inc first reported a position in AMED in Q4 2017 and held it in 13 quarters. The position peaked at $2.17K in Q2 2025. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • AssetMark Inc reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • AssetMark Inc sold 22 Amedisys shares in Q3 2025, an estimated $2.17K.
  • AssetMark Inc first reported a position in Amedisys in Q4 2017 and held it in 13 quarters.
  • AssetMark Inc's Amedisys position peaked at $2.17K in Q2 2025.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on AssetMark Inc's 13F filing for Q3 2025, filed 6 Nov 2025.